川北医学院学报
川北醫學院學報
천북의학원학보
JOURNAL OF NORTH SICHUAN MEDICAL COLLEGE
2014年
4期
359-363
,共5页
黄湘宁%喻华%刘华%乔宁%殷琳
黃湘寧%喻華%劉華%喬寧%慇琳
황상저%유화%류화%교저%은림
胆道感染%病原菌分布%耐药性
膽道感染%病原菌分佈%耐藥性
담도감염%병원균분포%내약성
Biliary tract infection%Pathogens%Drug resistance
目的:了解四川地区胆道感染的病原菌分布及其对抗生素敏感性的变化,为临床合理用药提供参考和依据。方法:将2012年1月至2013年12月四川地区54家医院分离自胆道病原菌进行鉴定及抗菌药物敏感试验,依据2013年CLSI标准判断结果,使用WHONET 5.6软件进行数据分析。结果:54家医院两年间自胆道共分离出1886株细菌,其中包含了65种细菌,革兰氏阴性杆菌1469株(1469/1886,77.9%),革兰氏阳性球菌399株(399/1886,21.2%),排列前5位的细菌依次为:大肠埃希菌669株(669/1886,35.5%)、肺炎克雷伯菌194株(194/1886,10.3%)、粪肠球菌152株(152/1886,8.1%)、铜绿假单胞菌133株(133/1886,7.1%)、屎肠球菌152株(125/1886,6.6%)。其中肠杆菌科细菌对阿米卡星、头孢替坦、厄他培南仍保持相当高的抗菌活性,敏感率>90%;铜绿假单胞菌对阿米卡星、妥布霉素、头孢吡肟及头孢他啶的敏感率>70%;肠球菌对替考拉宁、替加环素仍100%敏感,对万古霉素的敏感率也高于90%。结论:胆道感染的细菌谱以肠道细菌最为常见,病原菌种类多样,耐药性不断变迁,及时了解病原菌分布及抗生素耐药性可为临床经验性治疗提供依据。
目的:瞭解四川地區膽道感染的病原菌分佈及其對抗生素敏感性的變化,為臨床閤理用藥提供參攷和依據。方法:將2012年1月至2013年12月四川地區54傢醫院分離自膽道病原菌進行鑒定及抗菌藥物敏感試驗,依據2013年CLSI標準判斷結果,使用WHONET 5.6軟件進行數據分析。結果:54傢醫院兩年間自膽道共分離齣1886株細菌,其中包含瞭65種細菌,革蘭氏陰性桿菌1469株(1469/1886,77.9%),革蘭氏暘性毬菌399株(399/1886,21.2%),排列前5位的細菌依次為:大腸埃希菌669株(669/1886,35.5%)、肺炎剋雷伯菌194株(194/1886,10.3%)、糞腸毬菌152株(152/1886,8.1%)、銅綠假單胞菌133株(133/1886,7.1%)、屎腸毬菌152株(125/1886,6.6%)。其中腸桿菌科細菌對阿米卡星、頭孢替坦、阨他培南仍保持相噹高的抗菌活性,敏感率>90%;銅綠假單胞菌對阿米卡星、妥佈黴素、頭孢吡肟及頭孢他啶的敏感率>70%;腸毬菌對替攷拉寧、替加環素仍100%敏感,對萬古黴素的敏感率也高于90%。結論:膽道感染的細菌譜以腸道細菌最為常見,病原菌種類多樣,耐藥性不斷變遷,及時瞭解病原菌分佈及抗生素耐藥性可為臨床經驗性治療提供依據。
목적:료해사천지구담도감염적병원균분포급기대항생소민감성적변화,위림상합리용약제공삼고화의거。방법:장2012년1월지2013년12월사천지구54가의원분리자담도병원균진행감정급항균약물민감시험,의거2013년CLSI표준판단결과,사용WHONET 5.6연건진행수거분석。결과:54가의원량년간자담도공분리출1886주세균,기중포함료65충세균,혁란씨음성간균1469주(1469/1886,77.9%),혁란씨양성구균399주(399/1886,21.2%),배렬전5위적세균의차위:대장애희균669주(669/1886,35.5%)、폐염극뢰백균194주(194/1886,10.3%)、분장구균152주(152/1886,8.1%)、동록가단포균133주(133/1886,7.1%)、시장구균152주(125/1886,6.6%)。기중장간균과세균대아미잡성、두포체탄、액타배남잉보지상당고적항균활성,민감솔>90%;동록가단포균대아미잡성、타포매소、두포필우급두포타정적민감솔>70%;장구균대체고랍저、체가배소잉100%민감,대만고매소적민감솔야고우90%。결론:담도감염적세균보이장도세균최위상견,병원균충류다양,내약성불단변천,급시료해병원균분포급항생소내약성가위림상경험성치료제공의거。
Objective:Investigate the distribution of pathogenic bacteria in Sichuan of biliary tract infection and its variability in sen-sitivity of antibiotics in order to provide a reference basis for clinical rational drug usage. Methods:From January 2012 to December 2013,54 hospitals in Sichuan area are separated from the biliary pathogenic bacteria identification and antimicrobial susceptibility test. According to the 2013 CLSI,data analysis is done by using WHONET 5. 6 software. Results:1886 bacterial strains were isolated in two years from biliary,including 64 species of bacteria,1469 strains of gram negative bacilli (1469/1886,77. 9%),399 strains of gram positive cocci (399/1 886,21. 2%). The top 5 kinds of bacteria are as follows:669 strains of Escherichia coli (669/1 886,35. 5%), Klebsiella pneumoniae 194 strains (194/1 886,10. 3%),152 strains of Enterococcus faecalis (152/1 886,8. 1%),133 strains of Pseudomonas aeruginosa (133/1 886,7. 1%),152 strains of Enterococcus feces (125/1 886,6. 6%),among which the antimicrobial activity of Enterobacteriaceae to Amikacin,cefotetan,ertapenem still maintains fairly high( >90% sensitive rate);sensitivity of Pseudo-monas aeruginosa to Amikacin,tobramycin,cefepime and ceftazidime is higher than 70%;sensitivy of enterococcus to teicoplanin,tige-cycline is still 100%,and sensitivy to vancomycin is higher than 90%. Conclusion:The intestinal tract bacterial was the most common pathogen in biliary infection,which has species diversity,and a resistant variation. Timely understanding of the distribution of pathogens and antibiotic resistance can provide a basis for clinical empirical therapy.